July 24, 2011
Venue: ISTH Congress 2011 – Kyoto / Japan
Time: 13.00 - 14.30
Course Director: Prof. Karl Swedberg
1 CME credit
Learning Objectives:
- Increase awareness of key results from the major outcomes trials, placing the results in context of improving care across a wide range of ACS patients
- Cite differences between current and emerging oral antiplatelet therapies in terms of platelet function mechanisms
- Gain an understanding of role and utility of biomarkers in ACS as surrogates for future clinical outcome
- Understand the role of genetics on platelet function and its implications for optimizing antiplatelet therapy and patient outcomes
Target audience:
Trained cardiologists
Return to eventlist